These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 2128916

  • 1. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
    Balmain A, Brown K, Bremner R.
    Immunol Ser; 1990; 51():75-88. PubMed ID: 2128916
    [No Abstract] [Full Text] [Related]

  • 2. Reversion and rereversion in ras-transformed cells.
    Marshall CJ.
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract] [Full Text] [Related]

  • 3. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y, Gutierrez L, Wrathall LS, Lu YY, Blair DG, Clanton DJ, Hwang YW, Shih TY.
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [Abstract] [Full Text] [Related]

  • 4. Structure/function relationships of ras and guanosine triphosphatase-activating protein.
    Gibbs JB, Schaber MD, Garsky VM, Vogel US, Scolnick EM, Dixon RA, Marshall MS.
    Soc Gen Physiol Ser; 1990 May; 45():77-85. PubMed ID: 2198666
    [No Abstract] [Full Text] [Related]

  • 5. The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.
    Xu N, McCormick F, Gutkind JS.
    Oncogene; 1994 Feb; 9(2):597-601. PubMed ID: 8290270
    [Abstract] [Full Text] [Related]

  • 6. Genetic interaction between Rb and N-ras: differentiation control and metastasis.
    Takahashi C, Ewen ME.
    Cancer Res; 2006 Oct 01; 66(19):9345-8. PubMed ID: 17018584
    [Abstract] [Full Text] [Related]

  • 7. The ras gene family.
    Lowy DR, Willumsen BM.
    Cancer Surv; 1986 Oct 01; 5(2):275-89. PubMed ID: 3096566
    [Abstract] [Full Text] [Related]

  • 8. Role of p21ras in hormone signalling and cell growth/transformation.
    Blackmore PF.
    Adv Exp Med Biol; 1992 Oct 01; 321():143-6. PubMed ID: 1333165
    [No Abstract] [Full Text] [Related]

  • 9. Defining the mechanisms of transformation through analysis of revertant cells.
    Bassin RH, Benade LE.
    Immunol Ser; 1990 Oct 01; 51():15-47. PubMed ID: 2095917
    [No Abstract] [Full Text] [Related]

  • 10. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP.
    Exp Cell Res; 1993 Apr 01; 205(2):232-9. PubMed ID: 8482334
    [Abstract] [Full Text] [Related]

  • 11. Small GTP-binding proteins of the ras family: a conserved functional mechanism?
    Chardin P.
    Cancer Cells; 1991 Apr 01; 3(4):117-26. PubMed ID: 1909153
    [Abstract] [Full Text] [Related]

  • 12. Oncoproteins. GAPs in understanding Ras.
    Wigler MH.
    Nature; 1990 Aug 23; 346(6286):696-7. PubMed ID: 2201920
    [No Abstract] [Full Text] [Related]

  • 13. Signal transduction: untangling its golden promise.
    Edgington SM.
    Biotechnology (N Y); 1992 Feb 23; 10(2):152, 154. PubMed ID: 1368226
    [No Abstract] [Full Text] [Related]

  • 14. Rho small G protein and cytoskeletal control.
    Takai Y, Kaibuchi K, Sasaki T, Tanaka K, Shirataki H, Nakanishi H.
    Princess Takamatsu Symp; 1994 Feb 23; 24():338-50. PubMed ID: 8983086
    [Abstract] [Full Text] [Related]

  • 15. [Oncogenes and mitotic signal transduction].
    Tavitian A.
    Pathol Biol (Paris); 1992 Nov 23; 39(9):860. PubMed ID: 1538909
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA.
    Anticancer Res; 1985 Nov 23; 5(5):485-98. PubMed ID: 3904595
    [Abstract] [Full Text] [Related]

  • 17. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A.
    Cancer Res; 1996 May 15; 56(10):2387-92. PubMed ID: 8625316
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 19. Different structural organization of Ras and Rho effector domains.
    Self AJ, Paterson HF, Hall A.
    Oncogene; 1993 Mar 01; 8(3):655-61. PubMed ID: 8437849
    [Abstract] [Full Text] [Related]

  • 20. Role of GTPases and GTPase regulatory proteins in oncogenesis.
    Grunicke HH, Maly K.
    Crit Rev Oncog; 1993 Mar 01; 4(4):389-402. PubMed ID: 8353139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.